Radiant Path Therapy and Psychiatry · Grand Terrace, CA
Adults with treatment-resistant depression receive Spravato nasal spray treatment at our clinic in Grand Terrace, CA, where each plan starts with a full screening. Radiant Path Therapy and Psychiatry offers this U.S. Food and Drug Administration (FDA) approved nasal spray, with our psychiatry team overseeing each dosing decision.

01
Our psychiatry team treats the signs of treatment-resistant depression that remain after two or more antidepressants at an effective dose. Adults 18 and older with one or more signs receive esketamine for treatment-resistant depression when it suits their health history.
Persistent loss of pleasure (anhedonia)
Depression that returns soon after a period of improvement
Long-lasting or repeated major depressive episodes
Anxiety symptoms alongside depression
Physical symptoms such as chronic pain or headaches without a separate medical cause
Lasting difficulty with relationships and daily responsibilities
02
Our clinic administers every Spravato dose in person under direct staff observation. Clients spend more than two hours with us for each dose.
1
We review heart and blood vessel history and current medications before the first dose. We recommend other options for clients with an aneurysm (a bulging blood vessel) or past brain bleeding.
2
Before the first session, our staff explain pre-dose instructions to each client. Every client must bring a companion who drives them home after each session, since driving waits until the next day.
3
Some clients feel drowsy or briefly disconnected from their surroundings after the spray. Our staff stay nearby and check vital signs until these effects pass. Discharge follows a final safety review by our clinical team.
03
We plan the Spravato dosing schedule in two phases, with frequent sessions first and fewer sessions later. We adjust timing within each phase based on symptom response. Both phases follow the FDA-approved schedule for treatment-resistant depression.
1
In a standard induction phase, clients receive two Spravato treatments per week for four weeks, totaling eight sessions. Our prescribers review each client’s symptom changes during this phase before planning maintenance sessions.
2
In the maintenance phase, we schedule one session per week for weeks five through eight. From week nine, clients continue esketamine treatments weekly or every two weeks, and the treating prescriber sets the total length.
04
We prescribe Spravato, an antidepressant nasal spray, alone or with a daily oral antidepressant, as current FDA guidance allows. Adults with major depression and recent suicidal thoughts receive Spravato with an oral antidepressant. We base the choice on current medications and past responses.

05
As a ketamine-based nasal spray treatment, Spravato therapy at our practice includes psychiatric evaluation and ongoing medication management. Medication follow-up appointments take place in person or through telepsychiatry.
Clients who want added support meet with our therapists for talk therapy. Cognitive behavioral therapy (CBT) helps clients recognize and reframe negative thoughts. Behavioral activation adds small, planned daily actions that support mood improvements from esketamine therapy.
Our Intensive Outpatient Program (IOP) adds individual therapy and skill-building sessions several days a week. The Partial Hospitalization Program (PHP) offers full days of therapy with close psychiatric monitoring, and clients return home each evening.
06
Our staff manage prior authorization with the insurer before Spravato begins. We submit the required forms and update clients once the insurer responds.
Accepted plans include Aetna and Humana. Members of Blue Shield of California or Anthem Blue Cross Blue Shield have in-network access. We accept Cigna and Evernorth plans, plus UnitedHealthcare and Optum.
07
As a certified Spravato clinic, we participate in the Risk Evaluation and Mitigation Strategy (REMS) program. The FDA created this program to manage sedation and misuse risks linked to Spravato. Our clinic keeps each nasal spray device on site, so clients receive every dose here rather than at home. Our staff report each session to the program, which confirms our clinic meets FDA safety standards.

08
Clients meet with a prescriber and a therapist at one practice, without outside referrals. Both roles work from the same clinic, so clients schedule all care in one place.
Twice-weekly induction sessions require time away from work. Our team provides medical leave documentation for Family and Medical Leave Act (FMLA) and State Disability Insurance (SDI) claims.
Our team treats co-occurring anxiety and ADHD at our clinic near Barton Road in Grand Terrace. For clients with depression and past trauma, our therapists offer eye movement desensitization and reprocessing (EMDR).
09
Our Spravato team includes prescribers and therapists who work from this office. Prescribers oversee screening and dosing, while therapists support clients who choose talk therapy.

Psychiatric Nurse Practitioner
DNP, PMHNP-BC
Daniel Lucero, DNP, PMHNP-BC is a board-certified psychiatric nurse practitioner and Doctor of Nursing Practice graduate of Loma Linda University.

Certified Psychiatric Associate
DNP, PMHNP-BC
Justin Matar, DNP, PMHNP-BC is a board-certified psychiatric nurse practitioner trained at Loma Linda University.

Physician Assistant
PA-C, CAQ-Psychiatry
As a Psychiatry CAQ Physician Assistant, I blend urgent and general medicine with psychiatry, focusing on patient education and the physical-mental health connection.

Associate Clinical Social Worker
LPT, ASW, MSW
Melissa Rubalcava is an Associate Clinical Social Worker dedicated to helping individuals and couples navigate anxiety, trauma, identity challenges, and relationship stress.

Marriage & Family Therapist Associate
AMFT, EMDR
Briana Fisher is an Associate Marriage and Family Therapist committed to supporting individuals, couples, and families facing trauma, emotional distress, and relationship challenges.

Marriage & Family Therapist Associate
MRAS, CSC
Mak Ehtesham is a Mental Health Recovery and Addiction Specialist with a doctoral degree in Applied Clinical Psychology and more than a decade of experience in behavioral health.

Program Manager & Trauma Specialist
Deborah Sutton serves as the Program Manager at Radiant Path Therapy and Psychiatry and plays a central role in shaping the client experience.

Clinical Director
LMFT
Tiffany Komba is a Licensed Marriage and Family Therapist and the Clinical Director at Radiant Path Therapy and Psychiatry.

Associate Professional Clinical Counselor
APCC, EMDR Practitioner
My name is Kerri Reynolds and I am an Associate Professional Clinical Counselor (APCC) and EMDR practitioner with specialized experience providing trauma-informed care to individuals navigating a wide range of mental…

Associate Professional Clinical Counselor
ACSW, EMDR Practitioner
I bring a strong clinical foundation working with children, adolescents, adults, and families, along with experience providing trauma informed, evidence based care in diverse settings.

Associate Therapist
AMFT, APCC
Samantha, AMFT & APCC, supports life transitions, trauma, and stress using CBT/DBT, offering compassionate care to build insight, resilience, and confidence.
10
Our clinic is near the I-215 freeway, so travel time stays short for clients across the Inland Empire. Adults from both San Bernardino and Riverside counties attend Spravato treatment sessions at this location.
Colton
Loma Linda
San Bernardino
Highgrove
Riverside
Rialto
Bloomington
11
Our team begins insurance approval as soon as a client books, so treatment starts on schedule. Schedule a screening at Radiant Path Therapy and Psychiatry and begin Spravato nasal spray treatment at our REMS-certified clinic in Grand Terrace, CA. Book an appointment today.
12
Effects from a single dose end within hours, while antidepressant benefit depends on repeated sessions across both dosing phases. Our clinic offers both phases at this location.
Clinical trials found improvement as early as 24 hours for some adults. Others notice gradual change over several weeks. Our team sets expectations for timing before treatment begins.
Some adults see little change with Spravato. Studies comparing it with a placebo spray found benefit on average across participants. When Spravato brings limited benefit, we discuss other treatment options available at our practice.
Each Spravato device holds 28 milligrams (mg) of esketamine across two sprays. Doses use two or three devices, for a total of 56 mg or 84 mg per session. The first dose for treatment-resistant depression is 56 mg. Our prescribers adjust the dose based on response and side effects.
Spravato’s FDA approval covers major depressive disorder, while post-traumatic stress disorder (PTSD) and bipolar disorder fall outside it. Research on these conditions continues, and standard care for them uses other treatments. Our practice treats PTSD with trauma-focused therapy, and our team evaluates mood disorders to recommend appropriate care.